From: Thymidine Phosphorylase/β-tubulin III expressions predict the response in Chinese advanced gastric cancer patients receiving first-line capecitabine plus paclitaxel
TP Staining (n = 51)
Positive
Negative
CR+PR No.
14
8
SD No.
5
13
PD No.
6
Response rate (%)
56
30.8
P
0.069
Median PFS (days)
(95% CI)
156
(71.5-240.5)
107
(66.7-147.3)
0.613
Median OS (days)
365
(123.0-567.0)
214
(74.8-317.2)
0.017